Monolitum (Lansoprazole)

Lansoprazole, the active ingredient in Monolitum, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and erosive esophagitis in adult patients.

GNH USA supplies Monolitum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing by decreasing gastric acidity. - Erosive esophagitis: aids mucosal recovery and reduces further damage. - Helicobacter pylori eradication regimens: used in combination therapy to improve eradication rates.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: occasional loose stools. - Nausea: transient feeling of stomach upset. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: occasional difficulty passing stool.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal blood test results. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use with caution in liver disease. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term users: watch for bone density loss and magnesium deficiency. - Pregnancy and lactation: category B, discuss risks with healthcare provider. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Lansoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: slight increase in serum levels, observe for toxicity. - Methotrexate (high dose): potential for increased toxicity, check renal function.